Expertise in
3
conditions

Paul-gerhardt G. Schlegel

Josef Schneider Str. 2, 
Wuerzburg, BY, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Josef Schneider Str. 2, 
Wuerzburg, BY, DE 

Overview

Paul-gerhardt Schlegel practices practicing medicine in Wuerzburg, Germany.

Schlegel is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Rhabdoid Tumor, Acute Lymphoblastic Leukemia (ALL), Adrenocortical Carcinoma, Bone Marrow Transplant, and Orchiectomy.

They are actively involved in clinical research, co-authoring 91 peer reviewed articles and participating in 2 clinical trials.

Locations

Josef Schneider Str. 2, Wuerzburg, BY 97080, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
View 1 Less Clinical Trial

91 Total Publications

Outcomes of microaxial flow pump use in acute-on-chronic heart failure.
Outcomes of microaxial flow pump use in acute-on-chronic heart failure.
Journal: JHLT open
Published: April 09, 2026

Frequently Asked Questions about Paul-gerhardt G. Schlegel

Is Paul-gerhardt G. Schlegel a top-rated expert for Rhabdoid Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Paul-gerhardt G. Schlegel is classified as an Advanced expert for Rhabdoid Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paul-gerhardt G. Schlegel participate in research or clinical trials?

Yes. Paul-gerhardt G. Schlegel has published 91 articles and abstracts on conditions like Rhabdoid Tumor. You can view a list of Paul-gerhardt G. Schlegel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Schlegel's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile